| Profile | GDS1873 / 203340_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 236.477 | 59 |
| GSM40788 | control - Rep 2 | 202.404 | 54 |
| GSM40789 | control - Rep 3 | 175.458 | 49 |
| GSM40775 | androgen treated - Rep 1 | 216.735 | 56 |
| GSM40776 | androgen treated - Rep 2 | 224.178 | 57 |
| GSM40777 | androgen treated - Rep 3 | 151.439 | 44 |
| GSM40790 | estrogen treated - Rep 1 | 225.977 | 57 |
| GSM40791 | estrogen treated - Rep 2 | 201.775 | 54 |
| GSM40792 | estrogen treated - Rep 3 | 214.047 | 56 |
| GSM40784 | A + tamoxifen - Rep 1 | 198.325 | 53 |
| GSM40785 | A + tamoxifen - Rep 2 | 184.304 | 51 |
| GSM40786 | A + tamoxifen - Rep 3 | 193.937 | 53 |
| GSM40778 | A + anastrozole - Rep 1 | 231.015 | 58 |
| GSM40779 | A + anastrozole - Rep 2 | 180.742 | 51 |
| GSM40780 | A + anastrozole - Rep 3 | 179.881 | 51 |
| GSM40781 | A + letrozole - Rep 1 | 214.158 | 56 |
| GSM40782 | A + letrozole - Rep 2 | 176.96 | 50 |
| GSM40783 | A + letrozole - Rep 3 | 180.109 | 50 |